Search Form
First, enter a politician or zip code
Now, choose a category
 

Diana DeGette's Public Statements on Issue: Drugs

Office: U.S. House (CO) - District 1, Democratic
Date Title
April 23, 2014 Letter to Margaret Hamburg, Commissioner of the United States Food and Drug Administration - Recognize Naloxene as a Safe and Effective Opioid Overdose Reversal Drug for Over-the-Counter Use
Feb. 27, 2014 DeGette Highlights Dangers Of Drug Counterfeiting
March 8, 2013 DeGette And Coffman Re-Introduce Bipartisan Legislation To Respect States' Rights On Marijuana
Oct. 9, 2012 Letter to Chairman Upton, Chairman Pitts, and Chairman Stearns
May 10, 2012 DeGette, Rooney Legislation to Combat Drug Shortages Clears Committee
Feb. 21, 2012 DeGette Statement On FDA Drug Shortage Announcement
Feb. 17, 2012 Letter to Margaret Hamburg, Commissioner U.S. Food and Drug Administration - Take Action on Recommendations from the FDA's General and Plastic Surgery Devices Panel
Oct. 31, 2011 Rooney, DeGette Announce White House Support for Bill to Combat Drug Shortages
Oct. 31, 2011 Rooney, DeGette Announce White House Support for Bill to Combat Drug Shortages
Oct. 3, 2011 Letter to Chairman Upton and Chairman Stearns
Sept. 9, 2011 Letter to The Honorable Jon Leibowitz Chairman Federal Trade Commission
June 21, 2011 DeGette, Rooney Introduce Bill to Combat Drug Shortages
June 16, 2011 House Members Introduce Bipartisan Legislation to Combat Drug-Resistant Infections
June 15, 2011 Rep. Eshoo and Bipartisan Coalition Introduce Bill to Combat the Rise of Drug-Resistant Infections
June 15, 2011 House Members Introduce Bipartisan Bill to Combat the Rise of Drug-Resistant Infections
April 13, 2011 Hearing of the Oversight and Investigations Subcommittee of the Energy and Commerce Committee - "Import Safety: Status of FDA's Screening Efforts at the Border"
April 12, 2011 Dingell, Waxman, Pallone, & DeGette Introduce Drug Safety Enhancement Act
March 24, 2011 Letter to Mr. Gregory J. Divis President Ther-Rx Corporation Chief Executive Officer KV Pharmaceutical Company
March 14, 2011 New GAO Report Highlights Importance of Health Care Reform Law's Medicare Drug Savings for Seniors
March 4, 2011 Letter to The Honorable Joseph R. Pitts Chairman Subcommittee on Health
June 22, 2010 DeGette Applauds Tough New Tobacco Rules
June 25, 2009 Hearing Of The Health Subcommittee Of The House Committee On Energy And Commerce - Comprehensive Health Reform Discussion Draft, Day Three
June 12, 2009 DeGette Hails Passage Of Smoking Prevention Bill
June 11, 2009 Hearing Of The Health Subcommittee Of The House Energy And Commerce Committee - Emerging Health Care Issues: Follow-On Biologic Drug Competition
March 4, 2009 Smoking Bill Approved By Committee
June 26, 2008 Durbin, Degette & Platts Introduce Legislation to Strengthen Smoking Prevention Efforts
June 26, 2008 Legislation to Strengthen Smoking Prevention Efforts
May 1, 2008 Panel I of a Hearing of the Health Subcommittee of the House Energy and Commerce Committee - Drug Safety Provisions of the Food and Drug Administration Globalization Act Discussion Draft Legislation
May 1, 2008 Increased Resources and FDA Authority Key to Pharmaceutical Safety
Nov. 1, 2007 Hearing of the Subcommittee on Oversight & Investigations of the House Committee on Energy and Commerce - FDA Foreign Drug Inspection Program
Sept. 26, 2007 Hearing of the House Subcommittee on Health of the House Committee on Energy and Commerce - H.R. 3610, The Food and Drug Import Saftey Act
Feb. 7, 2007 Rep. DeGette Working to Cleanup Toxic Meth Labs
Nov. 15, 2005 DeGette Launches New Web Page to Help Seniors Confused by Complicated Medicare Rx Drug Plan
Feb. 9, 2005 White House Admits Medicare Drug Plan Will Cost $720 Billion…How Much Will Social Security Plan Really Cost
Skip to top
Back to top